texas instruments incorporated - TXN
TXN
Close Chg Chg %
217.55 -2.71 -1.25%
Open Market
214.84
-2.71 (1.25%)
Volume: 5.47M
Last Updated:
Jan 30, 2026, 3:35 PM EDT
Company Overview: texas instruments incorporated - TXN
TXN Key Data
| Open $216.27 | Day Range 213.06 - 216.46 |
| 52 Week Range 139.95 - 222.00 | Market Cap $198.96B |
| Shares Outstanding 908.62M | Public Float 907.13M |
| Beta 0.99 | Rev. Per Employee N/A |
| P/E Ratio 40.20 | EPS $5.48 |
| Yield 251.18% | Dividend $1.42 |
| EX-DIVIDEND DATE Jan 30, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 7.80M |
TXN Performance
| 1 Week | 13.27% | ||
| 1 Month | 26.21% | ||
| 3 Months | 35.62% | ||
| 1 Year | 18.61% | ||
| 5 Years | 32.16% |
TXN Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
41
Full Ratings ➔
About texas instruments incorporated - TXN
Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The company was founded in 1930 and is headquartered in Dallas, TX.
TXN At a Glance
Texas Instruments Incorporated
12500 TI Boulevard
Dallas, Texas 75243-0592
| Phone | 1-214-479-3773 | Revenue | 17.68B | |
| Industry | Semiconductors | Net Income | 5.00B | |
| Sector | Electronic Technology | 2025 Sales Growth | 13.049% | |
| Fiscal Year-end | 12 / 2026 | Employees | N/A | |
| View SEC Filings |
TXN Valuation
| P/E Current | 39.687 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 31.851 |
| Price to Sales Ratio | 8.958 |
| Price to Book Ratio | 9.67 |
| Price to Cash Flow Ratio | 22.14 |
| Enterprise Value to EBITDA | 20.588 |
| Enterprise Value to Sales | 9.476 |
| Total Debt to Enterprise Value | 0.084 |
TXN Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | N/A |
| Receivables Turnover | 9.008 |
| Total Asset Turnover | 0.505 |
TXN Liquidity
| Current Ratio | 4.353 |
| Quick Ratio | 2.832 |
| Cash Ratio | 1.545 |
TXN Profitability
| Gross Margin | 57.024 |
| Operating Margin | 34.725 |
| Pretax Margin | 32.293 |
| Net Margin | 28.283 |
| Return on Assets | 14.269 |
| Return on Equity | 30.148 |
| Return on Total Capital | 16.494 |
| Return on Invested Capital | 16.606 |
TXN Capital Structure
| Total Debt to Total Equity | 86.327 |
| Total Debt to Total Capital | 46.331 |
| Total Debt to Total Assets | 40.619 |
| Long-Term Debt to Equity | 83.254 |
| Long-Term Debt to Total Capital | 44.682 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Texas Instruments Incorporated - TXN
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 20.03B | 17.52B | 15.64B | 17.68B | |
Sales Growth
| +9.18% | -12.53% | -10.72% | +13.05% | |
Cost of Goods Sold (COGS) incl D&A
| 6.26B | 6.50B | 6.55B | 7.60B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 979.00M | 1.24B | 1.58B | 2.00B | |
Depreciation
| 925.00M | 1.18B | 1.51B | 1.92B | |
Amortization of Intangibles
| 54.00M | 63.00M | 72.00M | 81.00M | |
COGS Growth
| +2.41% | +3.88% | +0.72% | +16.07% | |
Gross Income
| 13.77B | 11.02B | 9.09B | 10.08B | |
Gross Income Growth
| +12.56% | -19.98% | -17.47% | +10.88% | |
Gross Profit Margin
| +68.76% | +62.90% | +58.14% | +57.02% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 3.37B | 3.69B | 3.75B | 3.94B | |
Research & Development
| 1.67B | 1.86B | 1.96B | 2.08B | |
Other SG&A
| 1.70B | 1.82B | 1.79B | 1.86B | |
SGA Growth
| +4.78% | +9.31% | +1.76% | +5.06% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | 257.00M | (124.00M) | 117.00M | |
EBIT after Unusual Expense
| 10.14B | 7.33B | 5.46B | 6.02B | |
Non Operating Income/Expense
| 106.00M | 440.00M | 496.00M | 230.00M | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 214.00M | 353.00M | 508.00M | 543.00M | |
Interest Expense Growth
| +16.30% | +64.95% | +43.91% | +6.89% | |
Gross Interest Expense
| 214.00M | 353.00M | 528.00M | 543.00M | |
Interest Capitalized
| - | - | - | 20.00M | - |
Pretax Income
| 10.03B | 7.42B | 5.45B | 5.71B | |
Pretax Income Growth
| +12.48% | -26.06% | -26.49% | +4.71% | |
Pretax Margin
| +50.09% | +42.34% | +34.86% | +32.29% | |
Income Tax
| 1.28B | 908.00M | 654.00M | 709.00M | |
Income Tax - Current - Domestic
| - | 1.26B | 967.00M | 620.00M | |
Income Tax - Current - Foreign
| - | 212.00M | 240.00M | 244.00M | |
Income Tax - Deferred - Domestic
| - | (223.00M) | (277.00M) | (139.00M) | |
Income Tax - Deferred - Foreign
| - | 32.00M | (22.00M) | (71.00M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | (40.00M) | (34.00M) | (24.00M) | |
Consolidated Net Income
| 8.71B | 6.48B | 4.78B | 5.00B | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 8.71B | 6.48B | 4.78B | 5.00B | |
Net Income Growth
| +12.58% | -25.64% | -26.27% | +4.73% | |
Net Margin Growth
| +43.48% | +36.97% | +30.53% | +28.28% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 8.71B | 6.48B | 4.78B | 5.00B | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 8.71B | 6.48B | 4.78B | 5.00B | |
EPS (Basic)
| 9.5076 | 7.1322 | 5.2358 | 5.5016 | |
EPS (Basic) Growth
| +13.44% | -24.98% | -26.59% | +5.08% | |
Basic Shares Outstanding
| 916.00M | 908.00M | 912.00M | 909.00M | |
EPS (Diluted)
| 9.406 | 7.071 | 5.1959 | 5.4469 | |
EPS (Diluted) Growth
| +13.81% | -24.82% | -26.52% | +4.83% | |
Diluted Shares Outstanding
| 926.00M | 916.00M | 919.00M | 913.00M | |
EBITDA
| 11.38B | 8.57B | 6.92B | 8.14B | |
EBITDA Growth
| +14.13% | -24.67% | -19.23% | +17.60% | |
EBITDA Margin
| +56.80% | +48.91% | +44.25% | +46.03% |
Snapshot
| Average Recommendation | HOLD | Average Target Price | 199.653 | |
| Number of Ratings | 41 | Current Quarters Estimate | 1.362 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 6.414 | |
| Last Quarter’s Earnings | 1.27 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 5.45 | Next Fiscal Year Estimate | 7.626 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 30 | 29 | 34 | 30 |
| Mean Estimate | 1.36 | 1.56 | 6.41 | 7.63 |
| High Estimates | 1.58 | 1.73 | 7.36 | 9.70 |
| Low Estimate | 1.22 | 1.38 | 5.85 | 6.52 |
| Coefficient of Variance | 4.60 | 4.63 | 5.15 | 8.17 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 12 | 12 | 13 |
| OVERWEIGHT | 3 | 4 | 4 |
| HOLD | 21 | 17 | 17 |
| UNDERWEIGHT | 0 | 1 | 1 |
| SELL | 5 | 6 | 5 |
| MEAN | Hold | Hold | Hold |
SEC Filings for Texas Instruments Incorporated - TXN
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Texas Instruments Incorporated - TXN
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Sep 23, 2025 | Pamela H. Patsley Director | 63,495 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 24, 2025 | Curtis Chatman Farmer Director | 1,335 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 28, 2025 | Richard K. Templeton Chairman; Director | 409,089 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $199.15 per share | 81,470,074.35 |
| Feb 28, 2025 | Richard K. Templeton Chairman; Director | 411,814 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $198.35 per share | 81,683,306.90 |
| Feb 28, 2025 | Richard K. Templeton Chairman; Director | 446,780 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $197.45 per share | 88,216,711.00 |
| Feb 28, 2025 | Richard K. Templeton Chairman; Director | 491,071 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $196.55 per share | 96,520,005.05 |
| Feb 28, 2025 | Richard K. Templeton Chairman; Director | 101,557 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 28, 2025 | Richard K. Templeton Chairman; Director | 198,557 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 28, 2025 | Richard K. Templeton Chairman; Director | 506,089 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $52.93 per share | 26,787,290.77 |
| Feb 28, 2025 | Richard K. Templeton Chairman; Director | 504,202 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $198.99 per share | 100,331,155.98 |
| Feb 28, 2025 | Richard K. Templeton Chairman; Director | 471,082 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $200.06 per share | 94,244,664.92 |
| Feb 28, 2025 | Richard K. Templeton Chairman; Director | 421,320 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $200.95 per share | 84,664,254.00 |
| Feb 28, 2025 | Richard K. Templeton Chairman; Director | 409,089 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $201.86 per share | 82,578,705.54 |
| Feb 28, 2025 | Richard K. Templeton Chairman; Director | 506,089 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $52.93 per share | 26,787,290.77 |
| Feb 26, 2025 | Richard K. Templeton Chairman; Director | 409,089 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $204.86 per share | 83,805,972.54 |
| Feb 26, 2025 | Janet F. Clark Director | 16,881 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $79.26 per share | 1,337,988.06 |
| Feb 26, 2025 | Richard K. Templeton Chairman; Director | 295,557 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 26, 2025 | Janet F. Clark Director | 10,816 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $203.62 per share | 2,202,353.92 |
| Feb 26, 2025 | Janet F. Clark Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 21, 2025 | Mark A. Blinn Director | 11,717 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $189.89 per share | 2,224,941.13 |